Singapore - The AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards were announced at the AusBiotech 2018 national conference in Brisbane. The Awards recognise innovative companies and individuals in Australia’s world-class biotechnology, medical technology and healthcare sectors.

Ms Kathy Connell, Senior Director New Ventures, ANZ, Johnson & Johnson Innovation, said: “Johnson & Johnson Innovation is extremely proud to sponsor these awards and celebrate the passion and creativity of these extraordinary recipients as they advance biomedical research and healthcare innovation. Each of them is a true champion of science, working on mission-critical improvements to healthcare access, impact and outcomes for patients all around the world.”

AusBiotech’s Chief Executive Officer, Lorraine Chiroiu, said: “The annual Awards are an opportunity to recognise outstanding contributions to the sector, for which we are very grateful, as they demonstrate what is possible when vision and dedication come together.”

“These awards recognise the notable highlights of the abundant excellence in our industry and encourage us with what can be achieved when innovation is accompanied by the business acumen needed to bring new health technologies to patients.”

This year the Awards received an overwhelming number of emerging company nominations, demonstrating the positive Australian environment our life sciences companies are working within. For the first time ever, joint-winners are being awarded for this category.

Industry Leadership Award: Dr Anna Lavelle

Company of the Year: Medicines Development for Global Health

Joint Emerging Company of the Year: Telix Pharmaceuticals and Microba